Filing Flows › Endovia Health Sciences (EDVA) › Q1 2026 › vs Q1 2025
Endovia Health Sciences (EDVA) Q1 2026 vs Q1 2025 (year over year)
Endovia Health Sciences's revenue fell $64K (-94%) from $69K in Q1 2025 to $4K in Q1 2026.
Endovia Health Sciences, Q1 2026: revenue $4K (-94% year over year), net earnings $2.5M, operating cash flow −$930K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $4K | $69K | −$64K | -94% |
| Other income, net | $3.5M | −$2.0M | $5.5M | — |
| Costs & expenses | $3.5M | $3.7M | −$236K | -6% |
| Operating costs | $983K | $1.7M | −$744K | -43% |
| Net earnings | $2.5M | −$3.7M | $6.2M | — |
| Cost of revenue | $2K | $43K | −$41K | -94% |
| Sales & marketing | $17K | $30K | −$13K | -42% |
| Other operating costs | $964K | $1.7M | −$690K | -42% |
| Operating cash sources | $3.6M | −$2.7M | $6.3M | — |
| Depreciation | $2K | $2K | $0 | 0% |
| Share-based compensation | $177K | $141K | $36K | +26% |
| Cash used in operations | $930K | $808K | $122K | +15% |
| Working capital & other | $3.6M | −$2.7M | $6.3M | — |
Questions
How much did Endovia Health Sciences's revenue grow year over year in Q1 2026?
Endovia Health Sciences's revenue fell $64K (-94%) from $69K in Q1 2025 to $4K in Q1 2026.